Chest CT and Clinical Features of COVID-19 Patients in the Early Stage of the Epidemic: An Observational Study from China

Mei Zeng, Xiangdong Jian, Ning Zhong, Yu Li, Zhao Hu, Jianchun Fei, Xinguo Hou, Fanli Meng, Tao Li, Yun Qiao, Yi Zhang, Wen‐Wu Bai, Huaibin Sun, Xiao Meng, Shaozhong Yang, Yuan Bian, Hao Wang, Xueyuan Yu, Guangcai Yu, Tianzi Jian, Cece Sun, Ya Liu, Jun SunResearch Square 2021 · DOI

Abstract

Background: COVID-19 had caused more than 2.8 million deaths globally, and the epidemic will persist for an extended period of time. We analyzed clinical features of patients in the early stage of the epidemic, so as to deepen the understanding of the disease. Methods: In this retrospective study, we included 84 confirmed cases of COVID-19 during February 1, 2020 and March 31, 2020. Baseline data were used to classify patients as moderate (57%) or severe/critical based on Chinese protocol. We focused on analyzing the differences in chest computed tomography (CT) between the two groups. Results: Of the 84 cases, 50 were male and the median age was 69 years. 55 (65%) patients had comorbidities at admission, more in the severe/critical group (P=0.040). 94% patients had bilateral lesions on CT, up to 68% had lesions involving all lobes. Ground glass opacification (GGO) (96%), consolidation (44%), Linear opacities (50%) and Air bronchogram (23%) were the mainly lesions. The lesion was gradually absorbed over time, but imaging abnormalities can persist for a long time. Compared with moderate cases, the severe/critical group had more pulmonary consolidation changes (P=0.044) and significantly higher CT severity Score (CTSS) (P=0.040). Lymphocyte counts were significantly lower (P=0.011) and NLR were higher (P=0.029) in severe/critical cases. Conclusions: Chest CT showed bilateral and multiple GGO and consolidation mainly. After treatment, pulmonary lesions were gradually absorbed over time, and imaging abnormalities can be persistent for a long time. Lung consolidation, CTSS, comorbidity, lymphocyte counts, and NLR may be predictors of severe COVID-19.

Introduction

During the initial outbreak in early 2020, clinicians faced a massive influx of patients with a poorly understood respiratory virus. While RT-PCR tests were the gold standard for diagnosis, they offered limited insight into the actual state of a patient's lungs or their likely clinical trajectory. The primary challenge was triage: identifying which patients would remain stable and which would progress to critical illness. This study addresses that gap by correlating clinical symptoms, laboratory findings, and radiological patterns via chest computed tomography (CT) with disease severity to identify reliable predictors of patient outcomes.

Methods

This retrospective, single-center observational study analyzed 84 confirmed COVID-19 patients treated at the Renmin Hospital of Wuhan University (East Branch) between February and March 2020. The cohort consisted of patients treated by a medical team from Shandong University Qilu Hospital sent to the epicenter during the early epidemic.

Patients were categorized into "Moderate" (57%) and "Severe/Critical" (43%) groups based on the Chinese national protocol, which considers clinical symptoms, respiratory rates, and oxygen saturation levels.

Clinical classification of COVID-19 severity based on the Chinese national protocol.

All patients underwent non-contrast helical chest CT scans. To quantify lung involvement, researchers utilized a CT Severity Score (CTSS). This semi-quantitative system assigns a score of 0–5 to each of the five lung lobes based on the percentage of involvement, resulting in a total possible score of 0–25. Statistical analysis compared demographics, comorbidities, laboratory results, and specific CT patterns between the severity groups.

Key Insights and Results

The study revealed several critical patterns in the early progression of COVID-19:

  • Demographics and Comorbidities: The median age of the cohort was 69 years, with a male predominance (60%). Comorbidities were present in 65% of patients and were significantly more prevalent in the severe/critical group ($P=0.040$), with hypertension and diabetes being the most frequent.
  • Radiological Patterns: Bilateral lung involvement was nearly universal (94%), and 68% of patients showed lesions in all five lobes. While Ground Glass Opacification (GGO) was the most common finding (96%), the presence of consolidation—dense patches where air is replaced by fluid or tissue—was a significant marker for severity, appearing in 63.9% of severe cases compared to 41.7% of moderate cases.
  • CT Severity Score (CTSS): The median CTSS was significantly higher in the severe group (15) than in the moderate group (11), reinforcing its value as a prognostic tool.
  • Laboratory Markers: Severe cases exhibited significantly lower lymphocyte counts ($P=0.011$) and higher Neutrophil-to-Lymphocyte Ratios (NLR) (median 3.5 vs. 2.2 in moderate cases). This suggests that NLR can serve as a simple, accessible indicator of systemic inflammatory stress.
Baseline demographics, comorbidities, and CT features for the 84-patient cohort.

The researchers also noted a "Second Week Peak," where pulmonary lesions typically reached maximum severity on CT approximately 14 days after symptom onset. Notably, imaging abnormalities often persisted long after clinical improvement, with some cases showing residual lesions up to 65 days post-onset.

Limitations and Future Work

The authors acknowledge that the study's small sample size (n=84) and retrospective, single-center design may limit the generalizability of the findings. Future research is needed to investigate long-term "imaging sequelae," such as permanent lung scarring, and to explore whether viral invasion of the central nervous system contributes to symptoms like headaches, which were observed more frequently in severe patients.

Conclusion

Chest CT scans and specific blood markers are more than just diagnostic tools; they are powerful prognostic indicators. Lung consolidation, high CTSS, comorbidities, low lymphocyte counts, and elevated NLR are significant predictors of severe COVID-19. Utilizing these markers early in the clinical course can help healthcare providers better triage patients and manage resources during respiratory epidemics.

Summary updated

Abstract

<title>Abstract</title> <bold>Background: </bold>COVID-19 had caused more than 2.8 million deaths globally, and the epidemic will persist for an extended period of time. We analyzed clinical features of patients in the early stage of the epidemic, so as to deepen the understanding of the disease.<bold>Methods: </bold>In this retrospective study, we included 84 confirmed cases of COVID-19 during February 1, 2020 and March 31, 2020. Baseline data were used to classify patients as moderate (57%) or severe/critical based on Chinese protocol. We focused on analyzing the differences in chest computed tomography (CT) between the two groups. <bold>Results</bold>: Of the 84 cases, 50 were male and the median age was 69 years. 55 (65%) patients had comorbidities at admission, more in the severe/critical group (P=0.040). 94% patients had bilateral lesions on CT, up to 68% had lesions involving all lobes. Ground glass opacification (GGO) (96%), consolidation (44%), Linear opacities (50%) and Air bronchogram (23%) were the mainly lesions. The lesion was gradually absorbed over time, but imaging abnormalities can persist for a long time. Compared with moderate cases, the severe/critical group had more pulmonary consolidation changes (P=0.044) and significantly higher CT severity Score (CTSS) (P=0.040). Lymphocyte counts were significantly lower (P=0.011) and NLR were higher (P=0.029) in severe/critical cases. <bold>Conclusions:</bold> Chest CT showed bilateral and multiple GGO and consolidation mainly. After treatment, pulmonary lesions were gradually absorbed over time, and imaging abnormalities can be persistent for a long time. Lung consolidation, CTSS, comorbidity, lymphocyte counts, and NLR may be predictors of severe COVID-19.
BibTeX
@inproceedings{zeng2021chest,
  author = {Mei Zeng and Xiangdong Jian and Ning Zhong and Yu Li and Zhao Hu and Jianchun Fei and Xinguo Hou and Fanli Meng and Tao Li and Yuan Li and Yun Qiao and Yi Zhang and Wen‐Wu Bai and Huaibin Sun and Xiao Meng and Shaozhong Yang and Yuan Bian and Hao Wang and Xueyuan Yu and Guangcai Yu and Tianzi Jian and Cece Sun and Ya Liu and Jun Sun},
  title = {{Chest CT and Clinical Features of COVID-19 Patients in the Early Stage of the Epidemic: An Observational Study from China}},
  booktitle = {Research Square},
  year = {2021},
  doi = {10.21203/rs.3.rs-543397/v1},
}
Figure